BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a strategic ...

BDX teams up with the Penn Institute for Immunology and Immune Health to launch a high-parameter immune profiling study.

Over the past decade, flow cytometry has undergone transformative advancements, notably with the adoption of spectral flow cytometry and the emergence of next-generation imaging cytometers. These ...

CAR-T translational research demands precise, reproducible, and scalable flow cytometry workflows. Manual centrifugation and antibody preparation steps remain major sources of variability and cell ...

The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted therapies, the promise of off-the-shelf chimeric antigen receptor (CAR) ...

At ELRIG 2025 in Stevenage, AstraZeneca’s Global Leader for Flow Cytometry, Dr Raffaello Cimbro, outlined how imaging flow ...

A new Swedish innovation uses machine learning and laser scanning to identify contaminated water in just 20 minutes, reducing ...

Becton Dickinson (BDX) just doubled down on immune system science by teaming up with the University of Pennsylvania’s Institute for Immunology and Immune Health to build advanced flow cytometry panels ...

IGIB, has launched India's first Centre of Excellence for Single-Cell Multiomics to enhance research in immunity, cancer, and ...

Urbanisation and a warmer climate means that more people want to swim in canals, harbours, and urban beaches. However, this means that they may ...

Learn more about whether Charles River Laboratories International, Inc. or Danaher Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial ...

Gold nanoparticles that cluster in response to T cell enzymes can predict cancer immunotherapy success days before tumors ...